Cargando…

UHPLC-HRMS-based metabolomic and lipidomic characterization of glioma cells in response to anlotinib

Anlotinib, as a promising oral small-molecule antitumor drug, its role in glioma has been only reported in a small number of case reports. Therefore, anlotinib has been considered as a promising candidate in glioma. The aim of this study was to investigate the metabolic network of C6 cells after exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yingying, Li, Zhuolun, Du, Qiuzheng, Li, Wenxi, Liu, Jiyun, Jia, Qingquan, Xue, Lianping, Zhang, Xiaojian, Sun, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192199/
https://www.ncbi.nlm.nih.gov/pubmed/37198251
http://dx.doi.org/10.1038/s41598-023-34902-5